why Oscar Health Inc [OSCR] is a Good Choice for Investors After New Price Target of $10.50

Oscar Health Inc [NYSE: OSCR] slipped around -0.19 points on Thursday, while shares priced at $11.03 at the close of the session, down -1.69%. The company report on January 18, 2024 at 8:00 AM that Oscar Health, Inc. 2023 Fourth Quarter and Full Year Earnings Conference Call.

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows:.

Compared to the average trading volume of 2.26M shares, OSCR reached a trading volume of 3159428 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Oscar Health Inc [OSCR]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OSCR shares is $10.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OSCR stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for Oscar Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 02, 2023.

The Average True Range (ATR) for Oscar Health Inc is set at 0.65, with the Price to Sales ratio for OSCR stock in the period of the last 12 months amounting to 0.46. The Price to Book ratio for the last quarter was 2.71.

How has OSCR stock performed recently?

Oscar Health Inc [OSCR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.18. With this latest performance, OSCR shares gained by 41.23% in over the last four-week period, additionally plugging by 32.10% over the last 6 months – not to mention a rise of 262.83% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OSCR stock in for the last two-week period is set at 67.38, with the RSI for the last a single of trading hit 67.22, and the three-weeks RSI is set at 67.07 for Oscar Health Inc [OSCR]. The present Moving Average for the last 50 days of trading for this stock 8.49, while it was recorded at 11.16 for the last single week of trading, and 7.26 for the last 200 days.

Oscar Health Inc [OSCR]: Deeper insight into the fundamentals

Oscar Health Inc’s liquidity data is similarly interesting compelling, with a Current Ratio set at 1.52.

Earnings analysis for Oscar Health Inc [OSCR]

With the latest financial reports released by the company, Oscar Health Inc posted -1.05/share EPS, while the average EPS was predicted by analysts to be reported at -1.16/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 9.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OSCR.

Insider trade positions for Oscar Health Inc [OSCR]

The top three institutional holders of OSCR stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in OSCR stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in OSCR stock with ownership which is approximately 5.8325%.